newsfilter
← Latest News
GlobeNewswire·

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic